If you’ve been diagnosed with uveal (ocular) melanoma, one of the most pressing questions is your prognosis, or odds of survival.
In up to 50% of uveal melanoma patients, the cancer may spread to the liver, where it is usually fatal. However, a new experimental treatment, meant to starve the liver tumor and help the body’s own immune system fight the cancer, may have the potential to impact survival.
To view Margot Kim’s full report on KFSN-TV, Fresno, CA, click here.
